DAPAFORD 5 M FORTE (Dapagliflozin (5mg) + Metformin (1000mg))

Dapaford-5 M Forte is a medication that consists of Dapagliflozin (5 mg) and Metformin (1000 mg) in a formulation designed for extended release. This combination is specifically intended for managing type 2 diabetes mellitus effectively. Dapagliflozin works by promoting the excretion of excess glucose via the kidneys, while Metformin improves the body’s sensitivity to insulin and decreases the liver’s production of glucose. This synergistic approach helps in maintaining stable blood sugar levels throughout the day, which is crucial for individuals with diabetes. By utilizing both mechanisms, Dapaford-5 M Forte aims to enhance overall glycemic control and reduce the likelihood of complications associated with diabetes. The extended-release feature allows for a gradual release of the medication into the bloodstream, ensuring prolonged efficacy and minimizing peaks and troughs in glucose levels. Regular monitoring and adherence to prescribed dosages are essential for optimal results when using this medication. As with any medication, it is important to have open discussions with healthcare providers regarding this treatment option, particularly concerning any other medications or health conditions that may influence its effectiveness and safety. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended.